Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos, M,Espinoza-Cámac N, OyagüezI, Del Río T, Rodríguez M
Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain
Expert Rev Pharmacoecon Outcomes Res. 2025;25(9):1337-1343. doi: 10.1080/14737167.2025.2556693
Ortega González E, Domínguez-Hernández R, Martínez Roma M, Ocete-Mochone MD, Carrodeguas A, González-Sánchez JL, Casado MA, García Deltoro M
Value of public health interventions for HIV, HBV and HCV integrated screening: The FOCUS-CRIVALVIR programme
Ann Epidemiol. 2025;109:31-37. doi: 10.1016/j.annepidem.2025.06.014
Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MA, Alvarez Aldean J
Estimating the economically justifiable price of nirsevimab vs. Standard of Practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: A cost-utility modeling study
BMJ Public Health. 2025;3(2):e002441. doi: 10.1136/bmjph-2024-002441
Gómez-Peralta F, Robles-Plaza M, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Ampudia-Blasco FJ
Clinical and Economic Value of Flash Glucose Monitoring Systems in the Management of People with Type 2 Diabetes Mellitus on Basal Insulin and Poor Glycemic Control
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025
Paladio-Duran N, Salinas-Ortega L, de la Cuadra-Grande A, Oyagüez I
Cost-effectiveness analysis of voclosporin vs mycophenolate or belimumab in the treatment of patients with lupus nephritis from the Spanish National Healthcare System perspective
62nd European Renal Association (ERA) Congress. Viena. 4-7 jun 2025
Fuentes A, Estévez-Escobar M, De Salazar A, Ruiz Escolano E ,Montiel N, Macías M, Alados JC, Aguilar JC, Pérez AB, Barrera Baena P, Cabezas T, Camelo-Castillo A, Palop B, González Grande R, Viciana I, Pinazo JM Bandera, Fernández Sánchez F, Lozano MC, Giráldez A, Domínguez MC, Jimeno Maté C, Ramírez Arellano E, Cordero P, Franco Álvarez De Luna F, del Pino P, De la Iglesia Salgado A, Pérez D, Sampedro A, López Garrido MA, Luzón-García MP, Salas-Coronas J, Roldán C, García F, Freyre C, Santamaría Rodríguez G, Rosales-Zabal JM, Domínguez-Hernández R, Casado MA, García F
Double reflex testing improvesthe efficacy and cost effectivenessof hepatitis delta diagnosis insouthern Spain
Sci Rep. 2025 May 2;15(1):15413
Cebrián A, Hernández AM, Ampudia-Blasco FJ, Bellido V, Carretero J, Gómez-Peralta F, Mezquita-Raya P
Análisis de coste-utilidad en España de los sistemas FreeStyle Libre frente a la auto-monitorización de la glucosa capilar en personas con diabetes mellitus tipo 2 en tratamiento con insulina basal y mal control glucémico
XXXVI Congreso de la Fundación Sociedad Española de Diabetes (FSED). A Coruña. 23-25 abr 2025
Forns X, Rodríguez M, Domínguez-Hernández R, Cantero H, Salinas-Ortega L, Ángel Casado M
Cost analysis of hidden hepatitis D virus infection in Spain
Gastroenterología y Hepatología. https://doi.org/10.1016/j.gastrohep.2025.502337
Castro Urda JL, Álvarez M, Cantero H, Ayala V, Vázquez M, Castro J, Salinas-Ortega L, Domínguez-Hernández R